A phase I trial of single, ascending doses of DRL 17822 in healthy volunteers.

Trial Profile

A phase I trial of single, ascending doses of DRL 17822 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jun 2010

At a glance

  • Drugs DRL 17822 (Primary)
  • Indications Atherosclerosis; Chronic obstructive pulmonary disease; Dyslipidaemias; Lipid metabolism disorders
  • Focus Adverse reactions
  • Sponsors Dr Reddys Laboratories
  • Most Recent Events

    • 29 Jun 2010 Results were reported at the 70th Annual Scientific Sessions of the American Diabetes Association.
    • 25 Jun 2010 Status changed from recruiting to completed.
    • 16 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top